These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33670646)

  • 21. siRNA‑induced ABCE1 silencing inhibits proliferation and invasion of breast cancer cells.
    Huang B; Zhou H; Lang X; Liu Z
    Mol Med Rep; 2014 Oct; 10(4):1685-90. PubMed ID: 25070080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella-zoster virus does not significantly induce cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle.
    Desloges N; Rahaus M; Wolff MH
    Med Microbiol Immunol; 2005 Jan; 194(1-2):25-31. PubMed ID: 15107989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection.
    Li XL; Blackford JA; Hassel BA
    J Virol; 1998 Apr; 72(4):2752-9. PubMed ID: 9525594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depleting ABCE1 expression induces apoptosis and inhibits the ability of proliferation and migration of human esophageal carcinoma cells.
    Huang B; Gong X; Zhou H; Xiong F; Wang S
    Int J Clin Exp Pathol; 2014; 7(2):584-92. PubMed ID: 24551278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the OAS/RNase L pathway by viruses.
    Drappier M; Michiels T
    Curr Opin Virol; 2015 Dec; 15():19-26. PubMed ID: 26231767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RNase L inhibitor (RLI) is induced by double-stranded RNA.
    Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
    J Interferon Cytokine Res; 1998 Dec; 18(12):1031-8. PubMed ID: 9877446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
    Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNase L triggers autophagy in response to viral infections.
    Chakrabarti A; Ghosh PK; Banerjee S; Gaughan C; Silverman RH
    J Virol; 2012 Oct; 86(20):11311-21. PubMed ID: 22875977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dom34 mediates targeting of exogenous RNA in the antiviral OAS/RNase L pathway.
    Nogimori T; Nishiura K; Kawashima S; Nagai T; Oishi Y; Hosoda N; Imataka H; Kitamura Y; Kitade Y; Hoshino SI
    Nucleic Acids Res; 2019 Jan; 47(1):432-449. PubMed ID: 30395302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase.
    Li G; Xiang Y; Sabapathy K; Silverman RH
    J Biol Chem; 2004 Jan; 279(2):1123-31. PubMed ID: 14570908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.
    Madden JC; Cui D; Brinton MA
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.
    Khabar KS; Dhalla M; Siddiqui Y; Zhou A; Al-Ahdal MN; Der SD; Silverman RH; Williams BR
    J Interferon Cytokine Res; 2000 Jul; 20(7):653-9. PubMed ID: 10926208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people.
    Fabre O; Breuker C; Amouzou C; Salehzada T; Kitzmann M; Mercier J; Bisbal C
    Cell Death Dis; 2014 Mar; 5(3):e1136. PubMed ID: 24651439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
    Malathi K; Dong B; Gale M; Silverman RH
    Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation.
    Bisbal C; Silhol M; Laubenthal H; Kaluza T; Carnac G; Milligan L; Le Roy F; Salehzada T
    Mol Cell Biol; 2000 Jul; 20(14):4959-69. PubMed ID: 10866653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of the interferon-inducible RNA-degrading enzyme, RNase L, by stress-inducing agents in the human cervical carcinoma cells.
    Pandey M; Bajaj GD; Rath PC
    RNA Biol; 2004 May; 1(1):21-7. PubMed ID: 17200614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.
    Martinand C; Montavon C; Salehzada T; Silhol M; Lebleu B; Bisbal C
    J Virol; 1999 Jan; 73(1):290-6. PubMed ID: 9847332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity.
    Kristiansen H; Scherer CA; McVean M; Iadonato SP; Vends S; Thavachelvam K; Steffensen TB; Horan KA; Kuri T; Weber F; Paludan SR; Hartmann R
    J Virol; 2010 Nov; 84(22):11898-904. PubMed ID: 20844035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.
    Anderson BR; Muramatsu H; Jha BK; Silverman RH; Weissman D; Karikó K
    Nucleic Acids Res; 2011 Nov; 39(21):9329-38. PubMed ID: 21813458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency.
    Daou S; Talukdar M; Tang J; Dong B; Banerjee S; Li Y; Duffy NM; Ogunjimi AA; Gaughan C; Jha BK; Gish G; Tavernier N; Mao D; Weiss SR; Huang H; Silverman RH; Sicheri F
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24802-24812. PubMed ID: 32958664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.